AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022
AbCellera (NASDAQ: ABCL) is set to announce its first quarter 2022 financial results on May 10, 2022, at 2:00 PM PT. An earnings conference call will follow the announcement, with a live audio webcast available on AbCellera's Investor Relations website. The company specializes in antibody discovery, collaborating with drug developers to optimize drug development processes. More details will be disclosed during the earnings call.
- Announcement of upcoming earnings call may indicate transparency and engagement with stakeholders.
- None.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20220411005730/en/
Inquiries
Media:
Business Development:
Investor Relations:
Source:
FAQ
When will AbCellera announce its first quarter 2022 financial results?
What time is AbCellera's earnings conference call?
How can I access the live audio webcast of the earnings call?